Endocrine Society Responds to Presidential Immigration Order

Share this content:
The Endocrine Society has pledged to support legal efforts aimed at overturning the president’s executive order.
The Endocrine Society has pledged to support legal efforts aimed at overturning the president’s executive order.

The Endocrine Society has released a statement responding to President Donald Trump's executive order on immigration.

The ban prevents citizens from Muslim-majority countries including Iran, Iraq, Libya, Somalia, Sudan, Syria, and Yemen from entering the United States. Leaders at The Endocrine Society, including society president Henry M. Kronenberg, MD, and Endocrine Society annual meeting chairperson Gary D. Hammer, MD, PhD, shared their concerns surrounding the ban.

“Society, at its core, is a global endeavor,” said Dr Kronenberg in a press release. “Collaborations that know no borders enhance biomedical research and clinical trials rely on international cooperation.”

“When scientists and clinicians from around the world connect and share knowledge, we see marvelous breakthroughs that shape how we prevent and treat diseases here in the United States as well as globally,” Dr Hammer said. “The Endocrine Society vigorously opposed policies that hinder scientific exchange.”

Members of The Endocrine Society hail from 122 countries. According to the press release, members who are now unable to attend the society's annual meeting have already begun reaching out.

The Endocrine Society has pledged to work with the scientific, medical, and legal communities to reverse the order. Additionally, the Society has begun exploring how best to provide technical access to accommodate those who may be prevented from attending ENDO 2017.

ENDO 2017 will take place April 1-4, 2017, in Orlando, Florida.


Reference

Endocrine Society responds to Trump's executive order on immigration [press release]. Washington, DC: The Endocrine Society. Published January 31, 2017. Accessed January 31, 2017. 

follow @EndoAdvisor

You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus